Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasm Female × Diagnostic Imaging × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Lung Neoplasms 4 Prostatic Neoplasms 3 Barrett Esophagus 3 Recurrence 2 Neoplasms 2 Multiple Pulmonary Nodules 2 Melanoma 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Spinal Fractures 1 Solitary Pulmonary Nodule 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Phyllodes Tumor 1 Osteoporosis 1 Nevus 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lung Diseases 1 Liver Cirrhosis 1 Inflammatory Bowel Diseases 1 Hypoxia 1

Interventions

Fulvestrant 2 venetoclax 1 pyrotinib 1 pertuzumab 1 palbociclib 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Letrozole 1 Induction Chemotherapy 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03217539 2018-02-07

WE

Dalarna County Council, Sweden

Phase NA Completed

133,065 enrolled

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡